%0 Journal Article
%T 非小细胞肺癌免疫治疗耐药性因素研究进展<br>Research Progress on Factors of Immunotherapy Resistance in Non-Small Cell Lung Cancer
%A 赵峰
%A 危志刚
%J Advances in Clinical Medicine
%P 846-852
%@ 2161-8720
%D 2025
%I Hans Publishing
%R 10.12677/acm.2025.153687
%X 非小细胞肺癌(NSCLC)是肺癌的主要类型&#65292;其治疗是临床研究的重点。近年来&#65292;新型治疗方式尤其是免疫检查点抑制剂的应用为NSCLC患者带来了新的治疗希望。但免疫治疗的耐药性问题仍是制约其疗效的关键因素。免疫治疗耐药性包括两大类&#65306;原发性耐药性和继发性耐药性&#65292;主要涉及内源性耐药性和外源性耐药性两个方面。内源性耐药机制主要涉及基因组和蛋白质组特征、肿瘤抗原与抗原递呈等方面异常。外源性耐药机制则与肿瘤微环境、免疫检查点共抑制等因素密切相关。本研究概述了NSCLC免疫治疗耐药性影响因子因素及其最新研究进展。<br>Non-small cell lung cancer (NSCLC) is a major focus type of lung cancer, and its treatment is a key area of clinical research. In recent years, the application of novel treatment methods, especially immune checkpoint inhibitors, has brought new hope for improving the survival of NSCLC patients. However, the issue of resistance to immunotherapy remains a critical factor limiting its efficacy. Immunotherapy resistance includes two main categories: primary resistance and secondary resistance, primarily involving intrinsic and extrinsic resistance mechanisms. Intrinsic resistance mechanisms mainly involve abnormalities in genomic and proteomic characteristics, tumor antigens, and antigen presentation. Extrinsic resistance mechanisms are closely related to the tumor microenvironment and immune checkpoint co-inhibition. This study summarizes the influencing factors of NSCLC immunotherapy resistance and the latest research progress.
%K 非小细胞肺癌&#65292
%K 免疫治疗&#65292
%K 影响因素&#65292
%K 研究进展<br>Non-Small Cell Lung Cancer
%K Immunotherapy
%K Influencing Factor
%K Research Progress
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=109158